Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients With Anaplastic Astrocytoma
Phase of Trial: Phase II
Latest Information Update: 22 Feb 2017
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Anaplastic astrocytoma
- Focus Therapeutic Use
- 28 Dec 2016 Status changed from active, no longer recruiting to completed.
- 09 Apr 2008 The expected completion date for this trial is now 1 Dec 2011 according to ClinicalTrials.gov.
- 19 Aug 2005 New trial record.